89Zr-DFO-REGN3767

REGN3767 radiolabeled with Zirconium-89 · Regeneron Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 89Zr-DFO-REGN3767, covering 2025-04-23 to 2025-04-23. Get the full timeline:

Most recent: Clinical Trial Update: 89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL) [EARLY_Phase 1]